Genmab A (GMAB) Current Taxes: 2018-2021
- Genmab A's Current Taxes rose 50.66% to -$52.72 in Q2 2021 from the same period last year, while for Jun 2021 it was -$52.72, marking a year-over-year increase of 50.66%. This contributed to the annual value of -$133.1 million for FY2020, which is 84.73% down from last year.
- Genmab A's Current Taxes amounted to -$52.72 in Q2 2021, which was up 100.00% from -$133.1 million recorded in Q4 2020.
- Genmab A's Current Taxes' 5-year high stood at -$5.08 during Q2 2019, with a 5-year trough of -$133.1 million in Q4 2020.
- Moreover, its 3-year median value for Current Taxes was -$106.87 (2020), whereas its average is -$41.0 million.
- Per our database at Business Quant, Genmab A's Current Taxes slumped by 2,001.60% in 2020 and then spiked by 50.66% in 2021.
- Genmab A's Current Taxes (Quarterly) stood at -$15.5 million in 2018, then crashed by 365.60% to -$72.1 million in 2019, then crashed by 84.73% to -$133.1 million in 2020, then surged by 50.66% to -$52.72 in 2021.
- Its last three reported values are -$52.72 in Q2 2021, -$133.1 million for Q4 2020, and -$106.87 during Q2 2020.
